BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.25B |
| 2 |
NVIDIA
NVDA
|
+$3.39B |
| 3 |
Chevron
CVX
|
+$3.11B |
| 4 |
Applovin
APP
|
+$2.76B |
| 5 |
Amazon
AMZN
|
+$2.16B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$3.58B |
| 2 |
ANSS
Ansys
ANSS
|
+$3.49B |
| 3 |
JNPR
Juniper Networks
JNPR
|
+$1.54B |
| 4 |
SKX
Skechers
SKX
|
+$830M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
+$784M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.12% |
| 2 | Financials | 12.68% |
| 3 | Consumer Discretionary | 10.08% |
| 4 | Healthcare | 9.39% |
| 5 | Communication Services | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3726
Cabaletta Bio
CABA
$455M
| $3.79M | ﹤0.01% |
1,620,872
+650,271
| +67% | +$1.12M |
|
|
CTNM
3727
Contineum Therapeutics
CTNM
$558M
| $3.78M | ﹤0.01% |
322,031
+156,585
| +95% | +$1.26M |
|
|
WYFI
3728
WhiteFiber Inc
WYFI
$935M
| $3.78M | ﹤0.01% |
+138,950
| New | +$2.71M |
|
|
HURA
3729
TuHURA Biosciences
HURA
$146M
| $3.77M | ﹤0.01% |
1,521,954
+183,728
| +14% | +$484K |
|
3730
Tenaya Therapeutics
TNYA
$168M
| $3.77M | ﹤0.01% |
2,327,201
-405,599
| -15% | -$409K |
|
3731
Lineage Cell Therapeutics
LCTX
$283M
| $3.77M | ﹤0.01% |
2,230,756
-29,992
| -1% | -$35.5K |
|
3732
Vanguard Intermediate-Term Treasury ETF
VGIT
$42.4B
| $3.77M | ﹤0.01% |
62,753
+59,814
| +2,035% | +$3.57M |
|
3733
MINISO
MNSO
$3.59B
| $3.74M | ﹤0.01% |
166,280
+73,973
| +80% | +$1.58M |
|
3734
ProFrac Holding
ACDC
$960M
| $3.71M | ﹤0.01% |
1,003,022
-23,406
| -2% | -$129K |
|
3735
Companhia Siderúrgica Nacional
SID
$1.15B
| $3.71M | ﹤0.01% |
2,472,508
+264,140
| +12% | +$381K |
|
3736
Lucid Diagnostics
LUCD
$183M
| $3.71M | ﹤0.01% |
3,669,292
+50,969
| +1% | +$55.7K |
|
|
VTYX
3737
DELISTED
Ventyx Biosciences
VTYX
| $3.68M | ﹤0.01% |
1,183,240
-184,765
| -14% | -$490K |
|
3738
TriSalus Life Sciences
TLSI
$353M
| $3.66M | ﹤0.01% |
787,864
+166,175
| +27% | +$778K |
|
3739
CION Investment
CION
$372M
| $3.66M | ﹤0.01% |
386,201
+74,761
| +24% | +$755K |
|
3740
Kimbell Royalty Partners
KRP
$1.5B
| $3.64M | ﹤0.01% |
269,813
+6,965
| +3% | +$97.9K |
|
3741
Greenwich LifeSciences
GLSI
$228M
| $3.61M | ﹤0.01% |
363,299
-3,882
| -1% | -$43.8K |
|
3742
Schwab Short-Term US Treasury ETF
SCHO
$12.9B
| $3.61M | ﹤0.01% |
147,797
-176,426
| -54% | -$4.29M |
|
3743
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.6B
| $3.6M | ﹤0.01% |
124,515
-33,205
| -21% | -$954K |
|
3744
Vanguard FTSE All-World ex-US ETF
VEU
$70B
| $3.58M | ﹤0.01% |
50,139
+45,370
| +951% | +$3.13M |
|
3745
Skillsoft
SKIL
$84.4M
| $3.56M | ﹤0.01% |
273,359
+16,929
| +7% | +$249K |
|
3746
C4 Therapeutics
CCCC
$476M
| $3.54M | ﹤0.01% |
1,595,639
-232,975
| -13% | -$559K |
|
3747
iShares Russell Mid-Cap Growth ETF
IWP
$20.8B
| $3.52M | ﹤0.01% |
24,747
-2,444
| -9% | -$345K |
|
|
HIMX
3748
Himax Technologies
HIMX
$2.61B
| $3.5M | ﹤0.01% |
396,920
+49,294
| +14% | +$423K |
|
|
PDS
3749
Precision Drilling
PDS
$1.07B
| $3.5M | ﹤0.01% |
62,057
+10,128
| +20% | +$554K |
|
|
ISBA
3750
Isabella Bank
ISBA
$312M
| $3.49M | ﹤0.01% |
98,924
+5,892
| +6% | +$191K |
|
Similar funds
BlackRock's Q3 2025 Portfolio in Review
As of Q3 2025, BlackRock held 5,636 positions worth $5.71T, up 8.7% from $5.25T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
BlackRock's Q3 2025 filing shows 188 new, 2,412 increased, 2,226 reduced and 181 closed positions. Its largest new stake was Paramount Skydance Corp: 16,557,304 shares worth $313M. The largest sale was Hess, an estimated $3.58B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Financials and Consumer Discretionary.
- BlackRock's largest Q3 2025 buy was Paramount Skydance Corp: 16,557,304 shares worth $313M.
- BlackRock added most to Microsoft in Q3 2025, an estimated $5.25B increase.
- BlackRock's biggest Q3 2025 reduction was Costco, cutting an estimated $769M.
- BlackRock fully exited Hess in Q3 2025, selling an estimated $3.58B.
- BlackRock's ten largest holdings make up 30% of its $5.71T portfolio in Q3 2025.
- BlackRock opened 188 new positions and closed 181 in Q3 2025.
- BlackRock's portfolio value rose 8.7% quarter-over-quarter to $5.71T.
Based on BlackRock's 13F filing for Q3 2025, filed 12 Nov 2025.